Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis

NCT03745417 is registered in ClinicalTrials.gov with Guangdong Provincial Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT03745417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03745417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis
Lead sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2021
Completion date
December 31, 2022
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect, drug toxicity, mesenchymal stromal cells, psoriasis